PATH

PATH 2-DAY DEADLINE ALERT: Hagens Berman Encourages UiPath (PATH) Investors with Substantial Losses to Contact its Attorneys Before Nov. 6th Deadline in Securities Fraud Class Action

Retrieved on: 
星期六, 十一月 4, 2023
Person, IPO, ARR, NYSE, Microsoft, Salesforce, Growth, Risk, UiPath, SAP, ServiceNow, PATH, Hagens Berman, IBM, SAN, Automation, Pharmaceutical industry, Life insurance

SAN FRANCISCO, Nov. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UiPath Inc. (NYSE: PATH) investors who suffered $250k or more in losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UiPath Inc. (NYSE: PATH) investors who suffered $250k or more in losses to submit your losses now .
  • Then, on Dec. 8, 2021, UiPath revealed its growth further stalled and disclosed its third consecutive ARR decline.
  • 30, 2022, UiPath revealed deeply disappointing ARR and revenue guidance that indicated declining growth trends were expected to continue.
  • “We’re focused on investors’ losses and are investigating whether UiPath may have misled investors about known trends that would adversely affect the company’s growth prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of UiPath Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 6, 2023 – (NYSE: PATH)

Retrieved on: 
星期四, 十一月 2, 2023
IPO, ARR, Microsoft, Fraud, NEXT, Salesforce, Risk, SAP, UiPath, ServiceNow, PATH, IBM, Class, Automation, Holding company, Security (finance)

Appointment as lead plaintiff is not required to partake in any recovery.

Key Points: 
  • Appointment as lead plaintiff is not required to partake in any recovery.
  • DEADLINE: November 6, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is November 6, 2023.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

PATH 5-DAY DEADLINE ALERT: Hagens Berman Encourages UiPath Inc. (PATH) Investors with Losses to Contact the Firm Before Nov. 6th Deadline in Securities Fraud Class Action Lawsuit

Retrieved on: 
星期三, 十一月 1, 2023
Person, IPO, ARR, NYSE, Microsoft, Salesforce, Growth, Risk, UiPath, SAP, ServiceNow, PATH, Hagens Berman, IBM, SAN, Automation, Pharmaceutical industry, Life insurance

SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UiPath Inc. (NYSE: PATH) investors who suffered $250k or more in losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UiPath Inc. (NYSE: PATH) investors who suffered $250k or more in losses to submit your losses now .
  • Then, on Dec. 8, 2021, UiPath revealed its growth further stalled and disclosed its third consecutive ARR decline.
  • 30, 2022, UiPath revealed deeply disappointing ARR and revenue guidance that indicated declining growth trends were expected to continue.
  • “We’re focused on investors’ losses and are investigating whether UiPath may have misled investors about known trends that would adversely affect the company’s growth prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of UiPath Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 6, 2023 – (NYSE: PATH)

Retrieved on: 
星期一, 十月 30, 2023
IPO, ARR, Microsoft, Fraud, NEXT, Salesforce, Risk, SAP, UiPath, ServiceNow, PATH, IBM, Class, Automation, Holding company, Security (finance)

Appointment as lead plaintiff is not required to partake in any recovery.

Key Points: 
  • Appointment as lead plaintiff is not required to partake in any recovery.
  • DEADLINE: November 6, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is November 6, 2023.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

UiPath Inc. (NYSE: PATH) faces securities fraud lawsuit after risk management failures – Hagens Berman Firm Encourages PATH Investors with Substantial Losses to Contact its Attorneys

Retrieved on: 
星期日, 十月 29, 2023
Person, IPO, ARR, NYSE, Microsoft, Salesforce, Growth, Risk, UiPath, SAP, ServiceNow, PATH, Hagens Berman, IBM, SAN, Automation, Pharmaceutical industry, Life insurance

SAN FRANCISCO, Oct. 29, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UiPath Inc. (NYSE: PATH) investors who suffered $250k or more in losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Oct. 29, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UiPath Inc. (NYSE: PATH) investors who suffered $250k or more in losses to submit your losses now .
  • Then, on Dec. 8, 2021, UiPath revealed its growth further stalled and disclosed its third consecutive ARR decline.
  • 30, 2022, UiPath revealed deeply disappointing ARR and revenue guidance that indicated declining growth trends were expected to continue.
  • “We’re focused on investors’ losses and are investigating whether UiPath may have misled investors about known trends that would adversely affect the company’s growth prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UiPath, Inc. - PATH

Retrieved on: 
星期五, 十月 27, 2023
ARR, NYSE, Prior, News, Growth, Pomerantz, LLP, Release, UiPath, PATH, Pharmaceutical industry, Cryptocurrency, Video game

NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UiPath, Inc. (“UiPath” or the “Company”) (NYSE: PATH).

Key Points: 
  • NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UiPath, Inc. (“UiPath” or the “Company”) (NYSE: PATH).
  • The investigation concerns whether UiPath and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On September 7, 2021, UiPath issued a release disclosing the Company’s financial results for the quarter ended July 31, 2021 (the “2Q22 Release”).
  • The 2Q22 Release revealed an unexpected slowdown in UiPath’s revenues and reported annual recurring revenue (“ARR”) metrics.

Terrapin Care Station, Hoboken’s First Cannabis Dispensary, Is Now Open

Retrieved on: 
星期三, 十一月 1, 2023
Alternative Medicine, Cannabis, Retail, Health, Other Retail, Natural Resources, Specialty, Station, Garden, The Station, Garden State, Timeline of cannabis laws in the United States, Patient, Heart, PATH, Drug

The Mile Square City is entering a historic new era as Hoboken's first medical cannabis dispensary , Terrapin Care Station (“The Station”), has officially opened its doors to medical marijuana patients at 10:00am on Friday, Oct. 27.

Key Points: 
  • The Mile Square City is entering a historic new era as Hoboken's first medical cannabis dispensary , Terrapin Care Station (“The Station”), has officially opened its doors to medical marijuana patients at 10:00am on Friday, Oct. 27.
  • The Station is the 14th dispensary in the Garden State to open exclusively to patients.
  • With deep local ties in the community, The Station’s Founder, Joseph Castelo, cites a community-wide desire for clean, high-quality curated cannabis as the driving force behind bringing the first legal cannabis dispensary to Hoboken.
  • The Station brings Hoboken a cannabis dispensary that offers patients a warm and welcoming staff and a truly singular cannabis retail experience.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts UiPath (PATH) to Securities Fraud Class Action Lawsuit, Encourages PATH Investors with Substantial Losses to Contact its Attorneys

Retrieved on: 
星期四, 十月 26, 2023
Person, IPO, ARR, NYSE, Microsoft, Salesforce, Growth, Risk, UiPath, SAP, ServiceNow, PATH, Hagens Berman, IBM, SAN, Automation, Pharmaceutical industry, Life insurance

SAN FRANCISCO, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UiPath Inc. (NYSE: PATH) investors who suffered $250k or more in losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges UiPath Inc. (NYSE: PATH) investors who suffered $250k or more in losses to submit your losses now .
  • Then, on Dec. 8, 2021, UiPath revealed its growth further stalled and disclosed its third consecutive ARR decline.
  • 30, 2022, UiPath revealed deeply disappointing ARR and revenue guidance that indicated declining growth trends were expected to continue.
  • “We’re focused on investors’ losses and are investigating whether UiPath may have misled investors about known trends that would adversely affect the company’s growth prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of UiPath Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 6, 2023 – (NYSE: PATH)

Retrieved on: 
星期三, 十月 25, 2023
IPO, ARR, Microsoft, Fraud, NEXT, Salesforce, Risk, SAP, UiPath, ServiceNow, PATH, IBM, Class, Automation, Holding company, Security (finance)

Appointment as lead plaintiff is not required to partake in any recovery.

Key Points: 
  • Appointment as lead plaintiff is not required to partake in any recovery.
  • DEADLINE: November 6, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is November 6, 2023.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

PATH 2-WEEK DEADLINE ALERT: Hagens Berman Encourages UiPath Inc. (PATH) Investors with Losses to Contact the Firm Before Nov. 6th Deadline in Securities Fraud Class Action

Retrieved on: 
星期一, 十月 23, 2023
Person, IPO, ARR, Microsoft, Salesforce, Growth, Risk, UiPath, SAP, ServiceNow, Hagens Berman, IBM, PATH, Automation, Pharmaceutical industry, Life insurance

Then, on Dec. 8, 2021, UiPath revealed its growth further stalled and disclosed its third consecutive ARR decline.

Key Points: 
  • Then, on Dec. 8, 2021, UiPath revealed its growth further stalled and disclosed its third consecutive ARR decline.
  • 30, 2022, UiPath revealed deeply disappointing ARR and revenue guidance that indicated declining growth trends were expected to continue.
  • In response to each of these events, the price of UiPath shares significantly declined.
  • “We’re focused on investors’ losses and are investigating whether UiPath may have misled investors about known trends that would adversely affect the company’s growth prospects,” said Reed Kathrein, the Hagens Berman partner leading the investigation.